The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact

  • Mario Pacileo | pacmario@yahoo.it Division of Cardiology, Hospital Umberto I, Nocera Inferiore (SA), Italy. https://orcid.org/0000-0002-6330-1738
  • Francesco Giallauria Department of Translational Medical Sciences, Federico II University of Naples, Italy. https://orcid.org/0000-0003-4119-9397
  • Cristina Savarese Division of Cardiology, Hospital Umberto I, Nocera Inferiore (SA), Italy.
  • Teresa Cirillo Division of Cardiology, Hospital Umberto I, Nocera Inferiore (SA), Italy.
  • Fabio Crescibene Division of Cardiology, COVID Hospital M. Scarlato, Scafati (SA), Italy.
  • Anna Di Lorenzo Department of Translational Medical Sciences, Federico II University of Naples, Italy.
  • Mariacarla Ferrillo Division of Cardiology, Hospital Umberto I, Nocera Inferiore (SA), Italy.
  • Maria Grazia Calabrese Division of Cardiology, Hospital Umberto I, Nocera Inferiore (SA), Italy.
  • Carlo Vigorito Department of Translational Medical Sciences, Federico II University of Naples, Italy.
  • Antonello D'Andrea Division of Cardiology, Hospital Umberto I, Nocera Inferiore (SA); Division of Cardiology, University of Campania L. Vanvitelli, Naples, Italy. https://orcid.org/0000-0002-9698-9145

Abstract

SARS-CoV-2 infection, responsible for COVID-19, can determine cardiac events, which require a quick diagnosis and management, and should not be overlooked due to the presence of COVID-19 infection. In some cases, cardiovascular symptoms can also be the first and only manifestation of SARS-CoV-2 infection. In patients with COVID-19, the full cardiovascular disease diagnostic algorithm can be hindered by logistic restrain mainly derived from the difficulty of transporting patients in critical conditions to Radiology or Hemodynamics wards. The echocardiography in SARS-CoV-2 pandemic can help for differential diagnosis of cardiac events, which can be related or unrelated by the infection and can likely impact on short-term prognosis. Indeed, transthoracic echocardiography plays a key role in the screen for CV complications of COVID-19 infection: it must be focused cardiac ultrasound study (FoCUS) performed at bedside. All transthoracic, transesophageal and stress echocardiograms in patients in which test results are unlikely to change the management strategy should be postponed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-05-19
Info
Issue
Section
COVID-19 - Collection of articles on the Coronavirus outbreak
Keywords:
COVID-19, echocardiography, transesophageal echocardiography, ARDS, PPE
Statistics
  • Abstract views: 213

  • PDF: 172
How to Cite
Pacileo, M., Giallauria, F., Savarese, C., Cirillo, T., Crescibene, F., Di Lorenzo, A., Ferrillo, M., Calabrese, M. G., Vigorito, C., & D’Andrea, A. (2020). The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact. Monaldi Archives for Chest Disease, 90(2). https://doi.org/10.4081/monaldi.2020.1358